Remote Director, Governance & Cross-Functional Operations

DTX Pharma, a Novartis Company; United States; Remote; USD 237,000 - 439,000; Full time

Job summary

Novartis is seeking a US Medical Affairs Director for Governance & Cross-functional Operations, remotely based in the U.S. The role leads operating models, governance, risk oversight, and continuous improvements across Medical Governance, Contracting & Business Solutions, and Clinical Drug Supply.

The position emphasizes stakeholder alignment, change management, and measurable value realization with enterprise-wide adoption of new tools and analytics. Travel of up to 20% is expected.

Qualifications

• Experience leading cross-functional operating models in a highly matrixed pharma environment.
• Proven ability to translate strategy into scalable governance, processes, and tools.
• Strong stakeholder management and change leadership in complex programs.

Responsibilities

• Design and implement cross-functional operating models across Medical Governance and Clinical Drug Supply.
• Lead transformation architecture, roadmaps, dashboards, and governance forums.
• Drive adoption, measure value realization, and ensure accountability across functions.
• Partner with Legal, Compliance, Finance and Quality to enable integrated execution.
• Promote AI-enabled solutions and data-driven decision making across USMA.

Skills

Medical affairs ops

Governance

Vendor management

AI fluency

Stakeholder management

Transformation leadership

Data analytics

Education

Bachelor’s degree in life sciences

Advanced degree preferred

Job description

Novartis is seeking a US Medical Affairs Director for Governance & Cross-functional Operations, remotely based in the U.S. The role leads operating models, governance, risk oversight, and continuous improvements across Medical Governance, Contracting & Business Solutions, and Clinical Drug Supply.

The position emphasizes stakeholder alignment, change management, and measurable value realization with enterprise-wide adoption of new tools and analytics. Travel of up to 20% is expected.